Skip to main content

Single-Use Assemblies Market worth $6.5 billion by 2027 – Exclusive Report by MarketsandMarkets™

Chicago, Nov. 03, 2022 (GLOBE NEWSWIRE) — According to the new market research report Single-Use Assemblies Market by Product (Bag, Filtration, Bottle Assemblies, Mixing Assemblies), Solution (Customized, Standard), Application (Filtration, Cell Culture, Storage, Fill-finish), End User (Pharma, Biopharma, CMOs) – Global Forecasts to 2027, the global single-use assemblies market is projected to reach USD 6.5 billion by 2027 from USD 2.7 billion in 2022, at a CAGR of 18.8% during the forecast period.

Browse in-depth TOC on “Single-Use Assemblies Market
177 – Tables
40 – Figures
236 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46226549

Scope of the Report:

Report Coverage Details
Market Size USD 6.5 billion by 2027
CAGR 18.8%
Historical Data 2020-2027
Base Year 2021
Forecast Period 2022-2027
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Product, By Solution,  By Application, By End User
Geographies Covered North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
Key Companies Profiled/Vendors Thermo Fisher Scientific, Inc. (US), Sartorius Stedim Biotech (France), Danaher Corporation (US), Merck KGaA (Germany), Avantor, Inc (US), Parker-Hannifin Corporation (US), Saint-Gobain (France), Repligen Corporation (US), Corning Incorporated (US), Entegris, Inc. (US), Meissner Filtration Products (US), NewAge Industries (US), Antylia Scientific (US), Lonza (Basel), Romynox B.V (Hague), FlexBiosys, Inc. (US), Keofitt A/S (Denmark), Intellitech, Inc. (US), Dover Corporation (US), Foxx Life Sciences (US), TSE Industries Inc. (US), Fujimori Kogyo Co. Ltd (Japan), Michelin (France), Cellexus International Ltd (UK), and Fluid Flow Products (US).
Key Market Opportunities Emerging Countries
Key Market Drivers Increasing Biopharmaceutical R&D is projecting the market growth

Growth in the single use assemblies market can primarily be attributed to the major advantages of single-use technologies over traditional stainless steel assemblies, such the low risk of cross-contamination and less capital investment. The increasing biopharmaceutical R&D expenditure and propelled investment in biologics market are also some of the factors driving the market growth.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=46226549

Based on solution, the single use assemblies market is segmented into standard and customized solutions. Standard solutions held a dominant share of the market in 2021. The adoption of standard solutions is high in the pharmaceutical & biopharmaceutical industries due to the advantages these solutions offer, such as manufacturing process efficiency with reduced capital costs, improved flexibility with the use of pre-qualified components for building assemblies. The custom solution is likely to grow at faster pace owing to various factors such as decreasing lead time required for custom solution coupled with reduced labour expense and time for end user.

Based on product, the market is segmented into bag assemblies, filtration assemblies, bottle assemblies, mixing system assemblies, and other products. In 2021, bag assemblies held a dominant share in the product segment. Launch of new products coupled with increased research funding is driving the segmental growth. For instance, Thermo Fisher launched the CentriPAK BPC for closed-system handling of critical sterile liquids.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=46226549

Geographical Growth Scenario:

The global single use assemblies market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2021, North America reported for the largest share of the single use assemblies market followed by Europe and Asia Pacific respectively. The dominance of the region attributable to its well-established biopharmaceutical industry, wide availability of single-use assemblies offered by market leaders in the region. Asia Pacific region is likely to grow at faster pace during the forecast period of 2022-2027. Increase in vaccine production coupled with collaboration of pharma companies with CDMO’s is likely to have positive impact on single use assemblies’ market in coming years. Furthermore, Geographical expansions by key market players in order to increase manufacturing capacity is expected to have positive impact on the single use assemblies market growth in the region.

Key Players:

The prominent players in the single use assemblies market are Thermo Fisher Scientific, Inc. (US), Sartorius Stedim Biotech (France), Danaher Corporation (US), Merck KGaA (Germany), Avantor Inc. (US) and among others. These companies have adopted both organic and inorganic growth strategies, such as product launches and acquisitions, to maintain their leading positions in the market.

Browse Adjacent MarketsBiotechnology Market Research Reports & Consulting

Browse Related Reports:

Fill Finish Manufacturing Market

Single-Use Bioreactors Market

Cell Culture Market

Cell Culture Media Market

Single Use Bioprocessing Market

CONTACT: About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.